IMAZODAN structure
|
Common Name | IMAZODAN | ||
|---|---|---|---|---|
| CAS Number | 84243-58-3 | Molecular Weight | 240.26100 | |
| Density | 1.34g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C13H12N4O | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one |
|---|---|
| Synonym | More Synonyms |
| Density | 1.34g/cm3 |
|---|---|
| Molecular Formula | C13H12N4O |
| Molecular Weight | 240.26100 |
| Exact Mass | 240.10100 |
| PSA | 59.28000 |
| LogP | 1.25080 |
| Index of Refraction | 1.696 |
| InChIKey | VXMYWVMXSWJFCV-UHFFFAOYSA-N |
| SMILES | O=C1CCC(c2ccc(-n3ccnc3)cc2)=NN1 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933990090 |
|
~82%
IMAZODAN CAS#:84243-58-3 |
| Literature: Sircar, Ila; Duell, Bradley L.; Bobowski, George; Bristol, James A.; Evans, Dale B. Journal of Medicinal Chemistry, 1985 , vol. 28, # 10 p. 1405 - 1413 |
|
~%
IMAZODAN CAS#:84243-58-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1099 - 1101 |
|
~%
IMAZODAN CAS#:84243-58-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1099 - 1101 |
|
~%
IMAZODAN CAS#:84243-58-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1099 - 1101 |
|
~%
IMAZODAN CAS#:84243-58-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1099 - 1101 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan.
Cardiovasc. Drugs Ther. 3(1) , 29-42, (1989) Intense efforts during the last decade to identify a useful positive inotropic agent to replace digitalis for the treatment of congestive heart failure have led to the discovery of several dozen poten... |
|
|
Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.
J. Chromatogr. A. 336(2) , 446-51, (1984)
|
|
|
Effect of a new phosphodiesterase type III inhibitor as a coronary vasodilator and positive inotropic agent.
Cardiovasc. Res. 21(8) , 593-600, (1987) Isolated rabbit coronary arteries, aortic strips, and a working rabbit heart preparation were used to assess the positive inotropic and vasodilator effects of a newly developed positive inotropic comp... |
| Imazodanum |
| Cl 914 |
| Imazodanum [Latin] |
| IMAZODAN |
| 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinone |
| 3(2H)-Pyridazinone,4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl) |
| MFCD00867109 |
| Imazodan [INN] |